Fifteen brokerages covering C3.ai have collectively assigned an average recommendation of “Reduce,” with five advising sell, seven hold, two buy and one strong buy. The mean one-year price target set by these analysts stands at 21.92, reflecting a nearly 60% potential upside from current levels. Recent notes from Canaccord Genuity and Needham & Company reaffirmed hold ratings, while UBS upgraded its neutral view and raised its target, and Wedbush maintained an outperform stance. These varied assessments underscore cautious optimism tempered by concerns over near-term growth trajectories.

Company insiders have reduced their holdings significantly: the CEO sold 234,918 shares and the chairman divested 554,802 shares, representing position decreases of roughly 20% and 22%, respectively. Over the past 90 days insiders offloaded nearly 2.0 million shares. Meanwhile, institutional investors hold approximately 39% of outstanding shares, with 26.5% owned by insiders. Recent filings reveal new stakes by Silicon Valley Capital Partners and Parallel Advisors, alongside increased positions from Larson Financial Group and Clearstead Advisors, signaling that hedge funds and large money managers continue to recalibrate exposure based on evolving earnings and strategic execution.

In its latest quarter, C3.ai reported revenue of $75.2 million, marking a 20.3% year-over-year decline, but delivered earnings per share of negative $0.25, beating consensus by $0.08. The company’s net margin remains deeply negative at 108.1%, with return on equity and assets at negative 46.5% and 37.9%, respectively. On the strategic front, C3.ai solidified alliances with AWS, Google and Microsoft for cloud integration, extended its relationship with Baker Hughes in energy applications, and continues joint ventures with Booz Allen and Raytheon to penetrate defense and intelligence sectors. These partnerships aim to underpin a transition toward higher-margin AI application deployments and diversified revenue streams.